Interferon therapy for chronic hepatitis C in hemodialysis patients: Increased serum levels of interferon

Nephron

Volumn 80, Issue 1, 1998, Pages 51-56

  Uchihara, Masakatsu ^a   Izumi, Namiki ^a   Sakai, Yoshinori ^b   Yauchi, Tsunehito ^b   Miyake, Shozo ^a   Sakai, Takahiro ^a   Akiba, Takashi ^c   Marumo, Fumiaki ^c   Sato, Chifumi ^d  

^a MUSASHINO RED CROSS HOSPITAL   (Japan)

^b TSUCHIURA KYODO GENERAL HOSPITAL   (Japan)

^c Tokyo Medical and Dental University   (Japan)

^d TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Area under the curve; Half life; Hemodialysis; Hepatitis C; Interferon; Liver biopsy; Pharmacokinetics

Indexed keywords

ALPHA INTERFERON; AMINOTRANSFERASE; ANTIVIRUS AGENT; INTERFERON; RECOMBINANT ALPHA2B INTERFERON; VIRUS RNA;

ADULT; AMINOTRANSFERASE BLOOD LEVEL; AREA UNDER THE CURVE; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; DEPRESSION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG HALF LIFE; FEMALE; FEVER; HEMODIALYSIS; HEPATITIS C; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; UNCONSCIOUSNESS;

ADULT; BLOOD TRANSFUSION; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2B; INTERFERON-ALPHA; KIDNEY FAILURE, CHRONIC; LIVER; MALE; MIDDLE AGED; RENAL DIALYSIS; RNA, VIRAL; TIME FACTORS;

EID: 0031690013     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000045125     Document Type: Article

References (20)

1. Jeffers LJ, Pérez GO, De Medina MD, Ortiz-Interian CJ, Schiff ER, Reddy KR, Jiménez M, Bourgoignie JJ, Vaamonde CA, Houghton M, Choo QL, Kuo G: Hepatitis C infection in two urban hemodialysis units. Kidney Int 1990;38: 320-322.
2. Zeldis JB, Depner TA, Kuramoto IK, Gish RG, Holland PV: The prevalence of hepatitis C virus antibodies among hemodialysis patients. Ann Intern Med 1990;112:958-960.
3. Kuhns M, De Marina M, McNamare A, Jeffers LJ, Reddy R, Silva M, Ortiz-Interian C, Jiménez M, Schiff ER: Detection of hepatitis C virus RNA in hemodialysis patients. J Am Soc Nephrol 1994;4:1491-1497.
4. Chan TM, Lok ASF, Cheng IKP Chan RT: Prevalence of hepatitis C virus infection in hemodialysis patients. A longitudinal study comparing the results of RNA and antibody assays. Hepatology 1993;17:5-8.
5. Sakamoto N, Enomoto N, Marumo F, Sato C: Prevalence of hepatitis C virus infection among long-term hemodialysis patients: Detection of hepatitis C virus RNA in plasma. J Med Virol 1993;39:11-15.
6. Alter MJ, Margolis HS, Krawczynski K, Judson F, Mares A, Alexander WJ, Hu PA, Miller JK, Gerber MA, Sampliner PE, Meeks EL, Beach MJ: The natural history of community-acquired hepatitis C in the Unites States. N Engl J Med 1992;327:1899-1905.
7. Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshizawa K, Nakano Y, Furuta S, Akahane K, Nishioka K, Purcell RH, Alter HJ: Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus. Hepatology 1990;12:671-675.
8. Tsukuma H, Hiyama T, Tanaka S, Nakao M, Yabuuchi T, Kitamura T, Nakanishi K, Fujimoto I, Inoue A, Yamazaki H, Kawashima T: Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 1993;328:1797-1801.
9. Di Bisceglie AM, Martin P, Kassianides C, Lisker-Melman M, Murray L, Waggoner J, Goodman Z, Banks SM, Hoofnagel JH: Recombinant Interferon alpha therapy for chronic hepatitis C: A randomized, double-blind, placebo-controlled trial. N Engl J Med 1989;321: 1506-1510.
10. Davis GL, Balart LA, Schiff ER, Lindsay K, Bodenheimer HC, Perrillo RP, Carey W, Jacobson IM, Payne J, Dienstag JL, VanThiel DH, Tamburro C, Lefkowitch J, Albrecht J, Meschievitz C, Ortego TJ, Gibas A, Hepatitis International Therapy Group: Treatment of chronic hepatitis C with recombinant interferon alfa: A multicenter randomized, controlled trial N Engl J Med 1989;321:1501-1506.
11. Koenig P, Vogel W, Umlauft F, Weyrer K, Prommegger R, Lhotta K, Neyer U, Stummvoll HK, Gruenewald K: Interferon treatment for chronic hepatitis C infection in uremic patients. Kidney Int 1994;45:1507-1509.
12. Pol S, Thiers V, Carnot F, Zins B, Romeo R, Berthelot P, Brechet C: Efficacy and tolerance of α-2b interferon therapy on HCV infection of hemodialyzed patients. Kidney Int 1995;47: 1412-1418.
13. De Groote J, Desmet VJ, Gedigk P, Korb G, Popper H, Poulsen H, Scheuer PJ, Schmid M, Thaler H, Uehlinger E: A classification of chronic hepatitis. Lancet 1968;ii:626-628.
14. Okamoto H, Okada S, Sugiyama Y, Tanaka T, Sugai Y, Akahane Y, Machida A, Mishiro S, Yoshizawa H, Miyakawa Y, Mayumi M: Detection of hepatitis C virus by a two-stage polymerase chain reaction with two pairs of primers deduced from the 5′-noncoding region. Jpn J Exp Med 1990;60:215-222.
15. Okamoto H, Sugiyama Y, Okuda S, Kurai K, Akahane Y, Sugai Y, Tanaka T, Sato K, Tsuda F, Miyakawa Y, Mayumi M: Typing hepatitis C virus by polymerase chain reaction with type-specific primers: Application to clinical surveys and tracing infectious sources. J Gen Virol 1992;73:673-679.
16. Kato N, Yokosuka O, Hosoda K, Ito Y, Ohio M, Omata M: Quantification of hepatitis C virus by competitive reverse transcription-polymerase reaction: Increase of the virus in advanced liver disease. Hepatology 1993;18: 16-20.
17. Radwanski E, Perentesis G, Jacobs S, Oden E, Affrime M, Symchowicz S, Zampaglione N: Pharmacokinetics of interferon α-2b in healthy volunteers. J Clin Pharmacol 1987;27:432-435.
18. Cohen GA, Goffinet JA, Danabedian RK, Conn HO: Observations on decreased serum glutamic oxalacetic transaminase (SGOT) activity in azotemic patients. Ann Intern Med 1974;84:275-280.
19. Degott C, Degos F, Jungers P, Naret C, Courouce AM, Potet F, Crosnier J: Relationship between liver histopathological changes and HBsAg in 111 patients treated by long-term hemodialysis. Liver 1983;3:377-384.
20. Debure A, Degos F, Pol S, Degott C, Carnot F, Lugassy C, Lacombe M, Kreis H: Liver diseases and hepatic complications in renal transplant patients. Adv Nephrol 1988;17:375-400.